WallStreetZenWallStreetZen

NASDAQ: KALA
Kala Bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for KALA

Based on 2 analysts offering 12 month price targets for Kala Bio Inc.
Min Forecast
$15.00+150%
Avg Forecast
$16.50+175%
Max Forecast
$18.00+200%

Should I buy or sell KALA stock?

Based on 2 analysts offering ratings for Kala Bio Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KALA stock forecasts and price targets.

KALA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-19
lockedlocked$00.00+00.00%2024-05-17

1 of 1

Forecast return on equity

Is KALA forecast to generate an efficient return?
Company
N/A
Industry
36.88%
Market
59.09%

Forecast return on assets

Is KALA forecast to generate an efficient return on assets?
Company
N/A
Industry
15.86%

KALA earnings per share forecast

What is KALA's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$11.76
Avg 2 year Forecast
-$6.67

KALA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
KALA$6.00$16.50+175.00%Buy
IXHL$1.66N/AN/A
TXMD$1.73N/AN/A
BGXX$0.19N/AN/A
CYTH$0.68$0.95+39.71%Buy

Kala Bio Stock Forecast FAQ

Is Kala Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: KALA) stock is to Buy KALA stock.

Out of 2 analysts, 0 (0%) are recommending KALA as a Strong Buy, 2 (100%) are recommending KALA as a Buy, 0 (0%) are recommending KALA as a Hold, 0 (0%) are recommending KALA as a Sell, and 0 (0%) are recommending KALA as a Strong Sell.

If you're new to stock investing, here's how to buy Kala Bio stock.

What is KALA's earnings growth forecast for 2024-2025?

(NASDAQ: KALA) Kala Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 21.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Kala Bio's earnings in 2024 is -$38,717,000.On average, 2 Wall Street analysts forecast KALA's earnings for 2024 to be -$54,161,974, with the lowest KALA earnings forecast at -$57,917,142, and the highest KALA earnings forecast at -$50,406,805.

In 2025, KALA is forecast to generate -$30,732,485 in earnings, with the lowest earnings forecast at -$30,732,485 and the highest earnings forecast at -$30,732,485.

What is KALA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KALA) forecast ROE is N/A, which is considered weak.

What is KALA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year KALA price target, the average KALA price target is $16.50, with the highest KALA stock price forecast at $18.00 and the lowest KALA stock price forecast at $15.00.

On average, Wall Street analysts predict that Kala Bio's share price could reach $16.50 by Aug 19, 2025. The average Kala Bio stock price prediction forecasts a potential upside of 175% from the current KALA share price of $6.00.

What is KALA's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: KALA) Kala Bio's current Earnings Per Share (EPS) is -$13.76. On average, analysts forecast that KALA's EPS will be -$11.76 for 2024, with the lowest EPS forecast at -$12.57, and the highest EPS forecast at -$10.94. In 2025, KALA's EPS is forecast to hit -$6.67 (min: -$6.67, max: -$6.67).

What is KALA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KALA) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.86%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.